Header cover image

Swiss Pharmaceuticals & Biotech Spotless Management

Results

1

0 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

1 companies

Novartis

Market Cap: CHF 228.1b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 119.14

7D

3.1%

1Y

20.8%